These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23152491)

  • 21. Dyspnea as an end point in clinical trials of therapies for acute decompensated heart failure.
    Teerlink JR
    Am Heart J; 2003 Feb; 145(2 Suppl):S26-33. PubMed ID: 12594449
    [No Abstract]   [Full Text] [Related]  

  • 22. Predictors of early dyspnoea relief in acute heart failure and the association with 30-day outcomes: findings from ASCEND-HF.
    Mentz RJ; Hernandez AF; Stebbins A; Ezekowitz JA; Felker GM; Heizer GM; Atar D; Teerlink JR; Califf RM; Massie BM; Hasselblad V; Starling RC; O'Connor CM; Ponikowski P
    Eur J Heart Fail; 2013 Apr; 15(4):456-64. PubMed ID: 23159547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Therapeutic effect of recombinant human brain natriuretic peptide for treatment of decompensated heart failure: comparison with nitroglycerin].
    Xie CL; Meng SR; Wang W; Chen SM; Li P; Feng XG
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):839-42. PubMed ID: 18504215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Acute changes in the hemodynamic profile and circulating levels of atrial natriuretic peptide induced by dobutamine in severe heart failure].
    La Vecchia L; Bottero M; Centofante P; Bedogni F; Ometto R; Cera A; Fortunato A
    G Ital Cardiol; 1996 Aug; 26(8):863-74. PubMed ID: 9005168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Body Weight Change During and After Hospitalization for Acute Heart Failure: Patient Characteristics, Markers of Congestion, and Outcomes: Findings From the ASCEND-HF Trial.
    Ambrosy AP; Cerbin LP; Armstrong PW; Butler J; Coles A; DeVore AD; Dunlap ME; Ezekowitz JA; Felker GM; Fudim M; Greene SJ; Hernandez AF; O'Connor CM; Schulte P; Starling RC; Teerlink JR; Voors AA; Mentz RJ
    JACC Heart Fail; 2017 Jan; 5(1):1-13. PubMed ID: 28034373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic and therapeutic utility of B-type natriuretic peptide in patients with renal insufficiency and decompensated heart failure.
    McCullough PA; Kuncheria J; Mathur VS
    Rev Cardiovasc Med; 2003; 4 Suppl 7():S3-S12. PubMed ID: 14668695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Association of serum uric acid, plasma NT-proBNP, Hs-C reactive protein and invasive hemodynamic parameters in patients with heart failure].
    Zhang YH; Lü R; Zhao XY; Kang LM; Yang YJ; Zhang J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Feb; 37(2):126-9. PubMed ID: 19719987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemodynamic improvement of acutely decompensated heart failure patients is associated with decreasing levels of NT-proBNP.
    Knebel F; Schimke I; Diaz Ramirez I; Schattke S; Eddicks S; Borges AC; Baumann G
    Int J Cardiol; 2009 May; 134(2):260-3. PubMed ID: 18384896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nesiritide for secondary pulmonary hypertension in patients with end-stage heart failure.
    O'Dell KM; Kalus JS; Kucukarslan S; Czerska B
    Am J Health Syst Pharm; 2005 Mar; 62(6):606-9. PubMed ID: 15757881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased B-type natriuretic peptide during liver transplantation: relationship to invasively measured hemodynamic parameters.
    Huh IY; Kim YK; Shin WJ; Park SE; Bang JY; Hwang GS
    Transplant Proc; 2012 Jun; 44(5):1318-22. PubMed ID: 22664008
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Does nesiritide reduce dyspnea in decompensated heart failure?].
    Bernardo WM; Moreira FT
    Rev Assoc Med Bras (1992); 2012; 58(1):11-3. PubMed ID: 22392308
    [No Abstract]   [Full Text] [Related]  

  • 32. A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study.
    Kazanegra R; Cheng V; Garcia A; Krishnaswamy P; Gardetto N; Clopton P; Maisel A
    J Card Fail; 2001 Mar; 7(1):21-9. PubMed ID: 11264546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
    Arnold LM; Crouch MA; Carroll NV; Oinonen MJ
    Pharmacotherapy; 2006 Aug; 26(8):1078-85. PubMed ID: 16863484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea.
    Mueller C; Scholer A; Laule-Kilian K; Martina B; Schindler C; Buser P; Pfisterer M; Perruchoud AP
    N Engl J Med; 2004 Feb; 350(7):647-54. PubMed ID: 14960741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of nesiritide in patients with acute decompensated heart failure.
    DeWald TA; Hernandez AF
    Expert Rev Cardiovasc Ther; 2010 Feb; 8(2):159-69. PubMed ID: 20136602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nesiritide in patients hospitalized for acute heart failure: does timing matter? Implication for future acute heart failure trials.
    Wong YW; Mentz RJ; Felker GM; Ezekowitz J; Pieper K; Heizer G; Hasselblad V; Metra M; O'Connor CM; Armstrong PW; Starling RC; Hernandez AF
    Eur J Heart Fail; 2016 Jun; 18(6):684-92. PubMed ID: 26817735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid assay brain natriuretic peptide and troponin I in patients hospitalized with decompensated heart failure (from the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness Trial).
    Shah MR; Hasselblad V; Tasissa G; Christenson RH; Binanay C; O'Connor CM; Ohman EM; Stevenson LW; Califf RM
    Am J Cardiol; 2007 Nov; 100(9):1427-33. PubMed ID: 17950802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Should acute treatment with inhaled beta agonists be withheld from patients with dyspnea who may have heart failure?
    Maak CA; Tabas JA; McClintock DE
    J Emerg Med; 2011 Feb; 40(2):135-45. PubMed ID: 18572345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interrelationship between haemodynamic state and serum intact parathyroid hormone levels in patients with chronic heart failure.
    Sugimoto T; Dohi K; Onishi K; Watanabe K; Sato Y; Sugiura E; Nakamori S; Nakajima H; Nakamura M; Ito M
    Heart; 2013 Jan; 99(2):111-5. PubMed ID: 23184010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. S3 detection as a diagnostic and prognostic aid in emergency department patients with acute dyspnea.
    Collins SP; Peacock WF; Lindsell CJ; Clopton P; Diercks DB; Hiestand B; Hogan C; Kontos MC; Mueller C; Nowak R; Chen WJ; Huang CH; Abraham WT; Amsterdam E; Breidthardt T; Daniels L; Hasan A; Hudson M; McCord J; Naz T; Wagoner LE; Maisel A
    Ann Emerg Med; 2009 Jun; 53(6):748-57. PubMed ID: 19232777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.